drugset / Trial / NCT02562144

A Clinical Trial of Cutaneous Xylocaine Spray to Reduce Intravenous Cannulation Pain in Adults

NCT02562144 ↗

Phase 4 Completed 17 enrolled Isala
RandomizedParallel-groupTriple-blindSupportive care

Summary

The enrolled subjects will get an intravenous cannulation in both elbows. The subject will get before xylocaine spray is placed, the intervention-arm, one intravenous cannulation in one of the elbows, the other intravenous cannulation is placed in the other arm before placebo spray is placed, the control arm. The pain score during insertion of the cannulation, the incidence of adverse events and the success rate and degree of difficulty to place an intravenous cannulation. The subjects and the one who place the cannulations will be blinded to the treatment.

Timeline

Start
2016-04-05
Primary completion
2016-04-06
Completion
2016-04-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified — Topical

Indications

No indication recorded.